Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Chemotherapy|Endocrine Breast Diseases
Interventions: DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Docetaxel|DRUG: Goserelin acetate|DRUG: Tamoxifen|DRUG: Letrozole
Sponsor: Zhiyong Yu